Form 8-K - Current report:
SEC Accession No. 0001102624-15-000349
Filing Date
2015-03-09
Accepted
2015-03-09 16:05:22
Documents
1
Period of Report
2015-03-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 THERAVANCE BIOPHARMA, INC. 8-K theravance8k.htm 8-K 22362
  Complete submission text file 0001102624-15-000349.txt   23568
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 15685206
SIC: 2834 Pharmaceutical Preparations